U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C9H13N3O14P3.3Na
Molecular Weight 549.1018
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Cytidine 5’-triphosphate trisodium

SMILES

[Na+].[Na+].[Na+].NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](COP([O-])(=O)OP([O-])(=O)OP(O)([O-])=O)[C@@H](O)[C@H]2O

InChI

InChIKey=HZQKYJNQQBPWQM-LLWADOMFSA-K
InChI=1S/C9H16N3O14P3.3Na/c10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(24-8)3-23-28(19,20)26-29(21,22)25-27(16,17)18;;;/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,21,22)(H2,10,11,15)(H2,16,17,18);;;/q;3*+1/p-3/t4-,6-,7-,8-;;;/m1.../s1

HIDE SMILES / InChI

Molecular Formula C9H13N3O14P3
Molecular Weight 480.1325
Charge -3
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula Na
Molecular Weight 22.98976928
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Enhanced P2X7 activity in human fibroblasts from diabetic patients: a possible pathogenetic mechanism for vascular damage in diabetes.
2004-07
Inhibition of E. coli CTP synthase by the "positive" allosteric effector GTP.
2004-06-01
Crystal structure of Escherichia coli cytidine triphosphate synthetase, a nucleotide-regulated glutamine amidotransferase/ATP-dependent amidoligase fusion protein and homologue of anticancer and antiparasitic drug targets.
2004-06-01
Expression of the pyrG gene determines the pool sizes of CTP and dCTP in Lactococcus lactis.
2004-06
Control of the CDPethanolamine pathway in mammalian cells: effect of CTP:phosphoethanolamine cytidylyltransferase overexpression and the amount of intracellular diacylglycerol.
2004-05-01
Competition between ammonia derived from internal glutamine hydrolysis and hydroxylamine present in the solution for incorporation into UTP as catalysed by Lactococcus lactis CTP synthase.
2004-04-01
Antiretroviral pipeline: new-drug reports from retroviruses conference.
2004-02-27
Cosegregation of C-insertion at position 961 with the A1555G mutation of the mitochondrial 12S rRNA gene in a large Chinese family with maternally inherited hearing loss.
2004-01-15
A fluorescent probe-labeled Escherichia coli aspartate transcarbamoylase that monitors the allosteric conformational state.
2004-01-09
Control of pyrimidine biosynthesis in "Pseudomonas alkanolytica" ATCC 21034.
2004
Regeneration of cofactors for use in biocatalysis.
2003-12
Cytotoxic cellular cholesterol is selectively removed by apoA-I via ABCA1.
2003-12
Divergent evolutions of trinucleotide polymerization revealed by an archaeal CCA-adding enzyme structure.
2003-11-03
Characterisation of Pt MYB1, an R2R3-MYB from pine xylem.
2003-11
Crystal structures of an archaeal class I CCA-adding enzyme and its nucleotide complexes.
2003-11
Incorporation of (alpha-P-borano)-2',3'-dideoxycytidine 5'-triphosphate into DNA by drug-resistant MMLV reverse transcriptase and Taq DNA polymerase.
2003-10-21
Antiviral dynamics and sex differences of zidovudine and lamivudine triphosphate concentrations in HIV-infected individuals.
2003-10-17
Trapping specific quaternary states of the allosteric enzyme aspartate transcarbamoylase in silica matrix sol-gels.
2003-08-20
Fold recognition, homology modeling, docking simulations, kinetics analysis and mutagenesis of ATP/CTP:tRNA nucleotidyltransferase from Methanococcus jannaschii.
2003-08-15
Nested cooperativity and salt dependence of the ATPase activity of the archaeal chaperonin Mm-cpn.
2003-07-17
[Research on motor dysfunction and the role of CTP after traumatic brain injury in rats].
2003-07
Phosphorylation of CTP synthetase on Ser36, Ser330, Ser354, and Ser454 regulates the levels of CTP and phosphatidylcholine synthesis in Saccharomyces cerevisiae.
2003-06-06
Dioxolane guanosine 5'-triphosphate, an alternative substrate inhibitor of wild-type and mutant HIV-1 reverse transcriptase. Steady state and pre-steady state kinetic analyses.
2003-05-23
Identification of lysine 122 and arginine 196 as important functional residues of rat CTP:phosphocholine cytidylyltransferase alpha.
2003-05-06
Limited proteolysis of Escherichia coli cytidine 5'-triphosphate synthase. Identification of residues required for CTP formation and GTP-dependent activation of glutamine hydrolysis.
2003-05
In vitro studies of transcript initiation by Escherichia coli RNA polymerase. 3. Influences of individual DNA elements within the promoter recognition region on abortive initiation and promoter escape.
2003-04-08
In vitro studies of transcript initiation by Escherichia coli RNA polymerase. 2. Formation and characterization of two distinct classes of initial transcribing complexes.
2003-04-08
In vitro studies of transcript initiation by Escherichia coli RNA polymerase. 1. RNA chain initiation, abortive initiation, and promoter escape at three bacteriophage promoters.
2003-04-08
Inhibition of hepatitis C virus RNA replication by 2'-modified nucleoside analogs.
2003-04-04
CTP:glycerol 3-phosphate cytidylyltransferase (TarD) from Staphylococcus aureus catalyzes the cytidylyl transfer via an ordered Bi-Bi reaction mechanism with micromolar K(m) values.
2003-03-21
Modulation of IA currents by capsaicin in rat trigeminal ganglion neurons.
2003-03
NTP pattern of avian embryonic red cells: role of RNA degradation and AMP deaminase/5'-nucleotidase activity.
2003-03
Effects of endogenous DNA base lesions on transcription elongation by mammalian RNA polymerase II. Implications for transcription-coupled DNA repair and transcriptional mutagenesis.
2003-02-28
Neighbouring bases in template influence base-pairing of isoguanine.
2003-02-01
Aspartate-107 and leucine-109 facilitate efficient coupling of glutamine hydrolysis to CTP synthesis by Escherichia coli CTP synthase.
2003-02-01
Association of the CD14 gene -159C polymorphism with progression of IgA nephropathy.
2003-02
HIV-1 resistance profile of the novel nucleoside reverse transcriptase inhibitor beta-D-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine (Reverset).
2003-01
Cellular pharmacology of D-d4FC, a nucleoside analogue active against drug-resistant HIV.
2003-01
Iodine-125 radioprobing of E. coli RNA polymerase transcription elongation complexes.
2003
The role of intersubunit interactions for the stabilization of the T state of Escherichia coli aspartate transcarbamoylase.
2002-12-20
Crystal structures of the Bacillus stearothermophilus CCA-adding enzyme and its complexes with ATP or CTP.
2002-12-13
Stabilization of the R allosteric structure of Escherichia coli aspartate transcarbamoylase by disulfide bond formation.
2002-12-06
Interactions of enantiomers of 2',3'-didehydro-2',3'-dideoxy-fluorocytidine with wild type and M184V mutant HIV-1 reverse transcriptase.
2002-12
Development of a pharmacodynamic model for HIV treatment with nucleoside reverse transcriptase and protease inhibitors.
2002-11
Steady-state kinetics of the glutaminase reaction of CTP synthase from Lactococcus lactis. The role of the allosteric activator GTP incoupling between glutamine hydrolysis and CTP synthesis.
2002-10
Differential processing of the Xenopus ATP(CTP):tRNA nucleotidyltransferase mRNA.
2002-09-27
An assay for cytidine 5(')-triphosphate synthetase glutaminase activity using high performance liquid chromatography.
2002-09-15
[Preliminary clinical study of application of cyntridini triphosphatis and dexamethasone in treatment of sudden deafness].
2002-08
The oxidized pyrimidine ribonucleotide, 5-hydroxy-CTP, is hydrolyzed efficiently by the Escherichia coli recombinant Orf135 protein.
2002-07-17
On-line microdialysis for enhanced resolution and sensitivity during electrospray mass spectrometry of non-covalent complexes and competitive binding studies.
2002
Patents
Substance Class Chemical
Created
by admin
on Wed Apr 02 19:46:35 GMT 2025
Edited
by admin
on Wed Apr 02 19:46:35 GMT 2025
Record UNII
25P4TB8BM9
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Cytidine 5?-(tetrahydrogen triphosphate), sodium salt (1:3)
Preferred Name English
Cytidine 5’-triphosphate trisodium
Common Name English
Trisodium [[[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] hydrogen phosphate
Systematic Name English
Cytidine triphosphate trisodium
Common Name English
Cytidine 5?-(tetrahydrogen triphosphate), trisodium salt
Common Name English
Code System Code Type Description
FDA UNII
25P4TB8BM9
Created by admin on Wed Apr 02 19:46:35 GMT 2025 , Edited by admin on Wed Apr 02 19:46:35 GMT 2025
PRIMARY
PUBCHEM
22803065
Created by admin on Wed Apr 02 19:46:35 GMT 2025 , Edited by admin on Wed Apr 02 19:46:35 GMT 2025
PRIMARY
CAS
54619-78-2
Created by admin on Wed Apr 02 19:46:35 GMT 2025 , Edited by admin on Wed Apr 02 19:46:35 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE